Dallah Healthcare Company (TADAWUL:4004)

Market Cap	11.94B -21.7%
Revenue (ttm)	3.77B +17.6%
Net Income	535.63M +13.7%
EPS	5.39 +11.8%
Shares Out	101.20M
PE Ratio	21.89
Forward PE	20.83
Dividend	2.00 (1.72%)
Ex-Dividend Date	Nov 11, 2025

Volume	204,148
Average Volume	81,361
Open	118.10
Previous Close	118.00
Day's Range	113.50 - 118.10
52-Week Range	109.00 - 157.30
Beta	0.05
RSI	39.55
Earnings Date	Mar 12, 2026

About Dallah Healthcare Company

Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was for...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1987
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4004

Financial Performance

In 2024, Dallah Healthcare Company's revenue was 3.21 billion, an increase of 8.93% compared to the previous year's 2.94 billion. Earnings were 471.20 million, an increase of 30.84%.